BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3892150)

  • 1. [DNA aneuploidy in children with acute leukemia: II. Correlation with the phenotype of blasts, clinical picture and course of disease].
    Ritter J; Hiddemann W; Wörmann B; Büchner T; Schellong G
    Klin Padiatr; 1985; 197(3):221-4. PubMed ID: 3892150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA aneuploidy in children with acute leukemia: I. Incidence and clinical significance within the scope of the BFM studies].
    Hiddemann W; Ritter J; Wörmann B; Budde M; Creutzig U; Schellong G; Büchner T; Riehm H
    Klin Padiatr; 1985; 197(3):215-20. PubMed ID: 3859703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers.
    Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; Ciudad J; López A; Cañizo MC; Garcia MA; San Miguel JF
    Cytometry; 1995 Mar; 22(1):22-5. PubMed ID: 7587729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes.
    Hiddemann W; Wörmann B; Göhde W; Büchner T
    Cancer; 1986 Jun; 57(11):2146-52. PubMed ID: 3457625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of aberrations in the karyotype of children with acute leukemia: a comparative analysis of cytogenetics and flow cytophotometry].
    Hiddemann W; Harbott J; Haas HO; Budde M; Büchner T; Lampert F
    Klin Padiatr; 1987; 199(3):161-4. PubMed ID: 3476802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical significance of DNA aneuploidy in acute leukemia.
    Hiddemann W; Wörmann B; Ritter J; Thiel E; Göhde W; Lahme B; Henze G; Schellong G; Riehm H; Büchner T
    Ann N Y Acad Sci; 1986; 468():227-40. PubMed ID: 3460478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
    ; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
    J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of DNA aneuploidy as a tumor marker].
    Takamoto S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
    Creutzig U; Ritter J; Heyen P; Berthold F; Henze G; Kabisch H; Lampert F; Niethammer D; Riehm H; Schellong G
    Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
    Vormoor J; Ritter J; Creutzig U; Schellong G
    Klin Padiatr; 1989; 201(4):227-32. PubMed ID: 2674529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA aneuploidy in children with relapsed acute lymphoblastic leukemia as measured by flow cytometry.
    Beck JD; Gromball J; Klingenbiel T; Ritter J; Henze G; Riehm H; Hiddermann W
    Haematol Blood Transfus; 1987; 30():509-12. PubMed ID: 3476382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A prognostic factor in childhood acute lymphoblastic leukemia: implication of cellular DNA contents. Children's Cancer and Leukemia Study Group].
    Katano N; Tsurusawa M; Kawai S; Fujimoto T
    Rinsho Ketsueki; 1989 Jul; 30(7):943-50. PubMed ID: 2810797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
    Riehm H; Reiter A; Schrappe M; Berthold F; Dopfer R; Gerein V; Ludwig R; Ritter J; Stollmann B; Henze G
    Klin Padiatr; 1987; 199(3):151-60. PubMed ID: 3306129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative cytology in leukemia research.
    Barlogie B; Maddox AM; Johnston DA; Raber MN; Drewinko B; Keating MJ; Freireich EJ
    Blood Cells; 1983; 9(1):35-55. PubMed ID: 6344934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
    Zhang RX; Yao EG
    Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of eosinophilia in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
    Creutzig U; Ritter J; Niederbiermann-Koczy G; Harbott J; Schellong G
    Klin Padiatr; 1989; 201(4):220-6. PubMed ID: 2674528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.